Synergistic Hemoglobin Conjugate Systems

The present disclosure relates to innovative systems that integrate thiosuccinyl-crosslinked hemoglobin conjugates with cutting-edge technologies like AI, IoT, blockchain, and advanced materials to create personalized medicine solutions, optimize treatment regimens, and enhance bioavailability.

The original patent disclosed pegylated thiosuccinyl-crosslinked hemoglobin conjugates with improved pharmacokinetics and pharmacodynamics. However, these conjugates have limitations in terms of personalized treatment, real-time monitoring, and targeted delivery. The new inventive concept addresses these limitations by synergistically combining the conjugates with distinct technologies to create more powerful systems.

The inventive concept encompasses a range of systems, including a personalized medicine system that leverages blockchain-based data storage and AI-powered analytics to predict optimal treatment regimens. Another embodiment involves an IoT-enabled sensor system that monitors patient vital signs and uses machine learning algorithms to optimize dosing. Additionally, a pharmaceutical composition is disclosed that incorporates graphene oxide nanoparticles for enhanced bioavailability and targeted delivery. A wearable device is also envisioned for monitoring conjugate efficacy, comprising a flexible sensor array, microcontroller, and wireless communication module.

The new claims introduce non-obvious combinations of the original thiosuccinyl-crosslinked hemoglobin conjugates with AI, IoT, blockchain, and advanced materials, resulting in innovative systems that significantly improve personalized medicine, treatment optimization, and bioavailability.

Alternative embodiments may include the use of other advanced materials, such as nanocellulose or liposomes, to enhance bioavailability and targeted delivery. Variations of the IoT-enabled sensor system could incorporate different types of sensors, such as electrochemical or optical sensors, to monitor patient vital signs.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine, precision health, and targeted therapies. The market for these systems is expected to grow substantially in the coming years, driven by the increasing demand for more effective and efficient healthcare solutions.